Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Aptevo Therapeutics Gross Profit 2014-2019 | APVO

Aptevo Therapeutics gross profit from 2014 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  
Aptevo Therapeutics Annual Gross Profit
(Millions of US $)
2018 $12
2017 $10
2016 $-2
2015 $17
2014 $29
2013 $
Aptevo Therapeutics Quarterly Gross Profit
(Millions of US $)
Q2 2019 $1
Q1 2019 $3
Q4 2018 $2
Q3 2018 $3
Q2 2018 $4
Q1 2018 $2
Q4 2017 $1
Q3 2017 $4
Q2 2017 $1
Q1 2017 $4
Q4 2016 $-9
Q3 2016 $-1
Q2 2016 $4
Q1 2016 $5
Q4 2015
Q3 2015 $3
Q2 2015 $3
Q4 2014
Q4 2013
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.030B $0.023B
Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.332B 13.36
Gilead Sciences (GILD) United States $83.535B 10.26
CSL (CSLLY) Australia $72.754B 0.00
Celgene (CELG) United States $70.130B 10.85
Vertex Pharmaceuticals (VRTX) United States $45.274B 48.93
Illumina (ILMN) United States $44.864B 52.71
Biogen (BIIB) United States $43.459B 7.72
Regeneron Pharmaceuticals (REGN) United States $31.428B 14.27
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.694B 12.49
SINO PHARMACEUT (SBMFF) China $17.812B 0.00
Incyte (INCY) United States $16.801B 49.44
BioMarin Pharmaceutical (BMRN) United States $13.639B 0.00
Exact Sciences (EXAS) United States $13.389B 0.00
Genmab (GNMSF) Denmark $12.505B 70.14
Seattle Genetics (SGEN) United States $11.770B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.952B 53.35
Alnylam Pharmaceuticals (ALNY) United States $9.408B 0.00
Galapagos (GLPG) Belgium $8.713B 0.00
QIAGEN (QGEN) Netherlands $7.627B 25.05
Bio-Techne Corp (TECH) United States $7.484B 51.70
Guardant Health (GH) United States $6.751B 0.00
Sarepta Therapeutics (SRPT) United States $6.346B 0.00
BeiGene (BGNE) Cayman Islands $6.313B 0.00
Amarin (AMRN) Ireland $6.051B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.022B 0.00
Exelixis (EXEL) United States $5.928B 15.41
Moderna (MRNA) United States $5.910B 0.00
Bluebird Bio (BLUE) United States $5.863B 0.00
Horizon Pharma Public (HZNP) Ireland $4.941B 12.56
ARGENX SE-ADR (ARGX) Netherlands $4.817B 0.00
Ascendis Pharma (ASND) Denmark $4.538B 0.00
China Biologic Products (CBPO) China $4.487B 28.01
Repligen (RGEN) United States $4.247B 82.41
Spark Therapeutics (ONCE) United States $3.926B 0.00
Blueprint Medicines (BPMC) United States $3.900B 0.00
Medicines (MDCO) United States $3.824B 0.00
MorphoSys AG (MOR) Germany $3.702B 0.00
Mirati Therapeutics (MRTX) United States $3.615B 0.00
Alkermes (ALKS) Ireland $3.334B 0.00
Immunomedics (IMMU) United States $3.273B 0.00
Reata Pharmaceuticals (RETA) United States $2.764B 0.00
Emergent Biosolutions (EBS) United States $2.686B 40.35
MyoKardia (MYOK) United States $2.668B 0.00
Genomic Health (GHDX) United States $2.640B 49.51
CRISPR Therapeutics AG (CRSP) Switzerland $2.597B 0.00
Arena Pharmaceuticals (ARNA) United States $2.551B 5.48
Ultragenyx Pharmaceutical (RARE) United States $2.502B 0.00
Amicus Therapeutics (FOLD) United States $2.450B 0.00
Halozyme Therapeutics (HALO) United States $2.383B 0.00
Acceleron Pharma (XLRN) United States $2.281B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.264B 0.00
NeoGenomics (NEO) United States $2.263B 121.06
Akcea Therapeutics (AKCA) United States $2.090B 0.00
Myriad Genetics (MYGN) United States $2.066B 21.68
Cambrex (CBM) United States $2.007B 25.37
Zai Lab (ZLAB) China $1.995B 0.00
Ligand Pharmaceuticals (LGND) United States $1.990B 25.17
UniQure (QURE) Netherlands $1.795B 0.00
Denali Therapeutics (DNLI) United States $1.745B 0.00
Insmed (INSM) United States $1.742B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.621B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.561B 0.00
REGENXBIO (RGNX) United States $1.451B 0.00
Coherus BioSciences (CHRS) United States $1.435B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.395B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.315B 0.00
Alector (ALEC) United States $1.273B 0.00
Editas Medicine (EDIT) United States $1.247B 0.00
Sangamo Therapeutics (SGMO) United States $1.230B 0.00
RA PHARMCTL INC (RARX) United States $1.183B 0.00
Fate Therapeutics (FATE) United States $1.168B 0.00
AnaptysBio (ANAB) United States $1.129B 0.00
Innoviva (INVA) United States $1.111B 3.21
Athenex (ATNX) United States $1.089B 0.00
Zymeworks (ZYME) Canada $1.031B 0.00
Epizyme (EPZM) United States $1.015B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.986B 0.00
Cara Therapeutics (CARA) United States $0.918B 0.00
Twist Bioscience (TWST) United States $0.904B 0.00
ANI Pharmaceuticals (ANIP) United States $0.879B 14.69
BAVARIAN NORDIC (BVNRY) Denmark $0.875B 0.00
Codexis (CDXS) United States $0.856B 0.00
WAVE Life Sciences (WVE) Singapore $0.850B 0.00
Arvinas (ARVN) United States $0.828B 0.00
Principia Biopharma (PRNB) United States $0.821B 427.88
Pharming Group (PHGUF) Netherlands $0.811B 0.00
Cytokineticsorporated (CYTK) United States $0.773B 0.00
Zealand Pharma (ZEAL) Denmark $0.766B 8.88
UROGEN PHARMA (URGN) United States $0.742B 0.00
Anika Therapeutics (ANIK) United States $0.741B 26.21
ZIOPHARM Oncology Inc (ZIOP) United States $0.733B 0.00
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.719B 25.96
Intellia Therapeutics (NTLA) United States $0.704B 0.00
Vericel (VCEL) United States $0.701B 0.00
Mesoblast (MESO) Australia $0.684B 0.00
Revance Therapeutics (RVNC) United States $0.621B 0.00
MiMedx (MDXG) United States $0.601B 0.00
DBV Technologies S.A (DBVT) France $0.581B 0.00
Heska (HSKA) United States $0.557B 72.15
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.532B 0.00
Retrophin (RTRX) United States $0.532B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.528B 0.00
Precision BioSciences (DTIL) United States $0.509B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.505B 0.00
Cellectis S.A (CLLS) France $0.503B 0.00
Stemline Therapeutics (STML) United States $0.495B 0.00
Intra-Cellular Therapies (ITCI) United States $0.482B 0.00
PHARMA MAR SA (PHMMF) Spain $0.468B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Syros Pharmaceuticals (SYRS) United States $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.440B 0.00
Merus (MRUS) Netherlands $0.438B 0.00
Puma Biotechnology (PBYI) United States $0.434B 0.00
BioDelivery Sciences (BDSI) United States $0.420B 0.00
Agenus (AGEN) United States $0.417B 0.00
CytomX Therapeutics (CTMX) United States $0.417B 0.00
Arcus Biosciences (RCUS) United States $0.414B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.409B 0.00
Bellus Health (BLU) Canada $0.407B 0.00
Adverum Biotechnologies (ADVM) United States $0.398B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.367B 0.00
Protagonist Therapeutics (PTGX) United States $0.362B 0.00
AC Immune SA (ACIU) Switzerland $0.362B 26.80
Kadmon Holdings (KDMN) United States $0.350B 0.00
Gritstone Oncology (GRTS) United States $0.349B 0.00
Theratechnologies (THERF) Canada $0.340B 0.00
Prothena (PRTA) Ireland $0.340B 0.00
Avid Bioservices (CDMO) United States $0.331B 0.00
Scholar Rock Holding (SRRK) United States $0.323B 0.00
Biofrontera AG (BFRA) Germany $0.312B 466.67
ADMA Biologics Inc (ADMA) United States $0.311B 0.00
Kindred Biosciences (KIN) United States $0.301B 0.00
Sorrento Therapeutics (SRNE) United States $0.299B 0.00
Albireo Pharma (ALBO) United States $0.297B 0.00
Starpharma Holdings (SPHRY) Australia $0.295B 0.00
Cellular Biomedicine (CBMG) United States $0.287B 0.00
Dynavax Technologies (DVAX) United States $0.287B 0.00
Geron (GERN) United States $0.271B 0.00
Seres Therapeutics (MCRB) United States $0.270B 0.00
Clovis Oncology (CLVS) United States $0.266B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.261B 0.00
Senesco Technologies (ELOX) United States $0.253B 0.00
MannKind (MNKD) United States $0.250B 0.00
ChromaDex (CDXC) United States $0.247B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.247B 0.00
Prometic Life Sciences (PFSCF) Canada $0.246B 0.00
PDL BioPharma (PDLI) United States $0.246B 6.32
Sutro Biopharma (STRO) United States $0.245B 0.00
Inovio Pharmaceuticals (INO) United States $0.241B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.238B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.236B 0.00
POXEL SA FRANCE (PXXLF) France $0.228B 0.00
Affimed (AFMD) Germany $0.226B 0.00
Spero Therapeutics (SPRO) United States $0.226B 0.00
Compugen (CGEN) Israel $0.222B 0.00
Athersys (ATHX) United States $0.221B 0.00
EXICURE INC (XCUR) United States $0.219B 0.00
Kamada (KMDA) Israel $0.207B 7.89
Five Prime Therapeutics (FPRX) United States $0.200B 0.00
Cue Biopharma (CUE) United States $0.199B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.197B 0.00
OSMOTICA PHARM (OSMT) United States $0.185B 0.00
Arsanis (XFOR) United States $0.183B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.183B 0.00
XOMA (XOMA) United States $0.179B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.179B 0.00
Alcobra (ARCT) United States $0.176B 0.00
Nicox SA (NICXF) France $0.173B 0.00
Enzo Biochem (ENZ) United States $0.170B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Acorda Therapeutics (ACOR) United States $0.163B 0.00
Dyadic (DYAI) United States $0.162B 0.00
Novavax (NVAX) United States $0.161B 0.00
Abeona Therapeutics (ABEO) United States $0.160B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.154B 0.00
Strongbridge Biopharma (SBBP) United States $0.148B 6.09
Cerecor (CERC) United States $0.143B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.143B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.143B 0.00
Northwest Biotherapeutics (NWBO) United States $0.143B 0.00
Adocia (ADOCY) France $0.140B 0.00
PHASEBIO PHARMA (PHAS) United States $0.139B 0.00
Emmaus Life Sciences (EMMA) United States $0.131B 0.00
NantKwest (NK) United States $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Aptinyx (APTX) United States $0.126B 0.00
Menlo Therapeutics (MNLO) United States $0.120B 0.00
Fortress Biotech (FBIO) United States $0.115B 0.00
SESEN BIO, INC (SESN) United States $0.110B 0.00
Celyad SA (CYAD) Belgium $0.101B 0.00
Aduro Biotech (ADRO) United States $0.098B 0.00
Vaccinex (VCNX) United States $0.097B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.097B 0.00
Verastem (VSTM) United States $0.096B 0.00
OvaScience (MLND) United States $0.093B 0.00
Trevena (TRVN) United States $0.093B 0.00
ARAVIVE, INC (ARAV) United States $0.091B 0.00
Arbutus Biopharma (ABUS) Canada $0.091B 0.00
Mersana Therapeutics (MRSN) United States $0.088B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.088B 0.00
VTv Therapeutics (VTVT) United States $0.086B 0.00
Checkpoint Therapeutics (CKPT) United States $0.083B 0.00
Idera Pharmaceuticals (IDRA) United States $0.082B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Synlogic (SYBX) United States $0.081B 0.00
Antibe Therapeutics (ATBPF) Canada $0.080B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.079B 0.00
Curis (CRIS) United States $0.075B 0.00
Liquidia Technologies (LQDA) United States $0.075B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.074B 0.00
NewLink Genetics (NLNK) United States $0.071B 0.00
Catalyst Biosciences (CBIO) United States $0.070B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
Orgenesis (ORGS) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Pluristem Therapeutics (PSTI) Israel $0.066B 0.00
Applied Genetic Technologies (AGTC) United States $0.066B 36.10
ASLAN Pharmaceuticals (ASLN) Singapore $0.063B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.061B 0.00
AquaBounty Technologies (AQB) United States $0.061B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
Unum Therapeutics (UMRX) United States $0.059B 0.00
Stellar Biotechnologies (EDSA) Canada $0.056B 0.00
VistaGen Therapeutics (VTGN) United States $0.051B 0.00
AIT Therapeutics (XAIR) United States $0.050B 0.00
Proteostasis Therapeutics (PTI) United States $0.049B 0.00
VBI Vaccines (VBIV) United States $0.048B 0.00
Oncobiologics (OTLK) United States $0.047B 0.00
Ophthotech (ISEE) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Evogene (EVGN) Israel $0.043B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.041B 0.00
Celldex Therapeutics (CLDX) United States $0.038B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
BIOCARDIA INC (BCDA) United States $0.037B 0.00
Celsion (CLSN) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Alimera Sciences (ALIM) United States $0.033B 0.00
Entera Bio (ENTX) Israel $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.028B 9.73
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Signal Genetics (MGEN) United States $0.028B 0.00
Clearside Biomedical (CLSD) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Apricus Biosciences (SEEL) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.023B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Novelion Therapeutics (NVLN) Canada $0.020B 0.00
TOCAGEN INC (TOCA) United States $0.019B 0.00
Soligenix (SNGX) United States $0.019B 0.00
Prana Biotechnology (ATHE) Australia $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
TrovaGene (TROV) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Bionano Genomics (BNGO) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00